STONE TOXICOLOGY TESTING

Drug overdose deaths increased dramatically from 1980 to 2016, causing a world-wide opioid epidemic. Urine drug testing (UDT) is an effective tool in pain management to monitor compliance with prescribed medications.(1) National guidelines recommend UDT not only to assess compliance but also to detect undisclosed substances and diversion.(2)

The Stone Way

  • Stone Clinical Laboratories offers state of the art LC/MS/MS testing with an extensive test menu, including controlled substances, elicit drugs, as well as specialized pain management and mental health product offerings.
  • Urine toxicology services at STONE monitor recent use of prescribed medications and identify possible illicit drug use, medication diversion, or abuse.
  • Our personalized testing menu offers the flexibility to meet patient’s individual needs at every stage of their treatment plan.
  • Offering an extensive drug-testing menu, Stone Clinical Laboratories leads the way in providing quick, thorough, and accurate toxicology reports from a urine specimen. We provide cutting edge technology, automated computer systems, and skilled laboratory staff; all to ensure accurate analyses that better enable physicians to make informed decisions.

13 Panel Presumptive Screening for Drug of Abuse (DOA) Testing

  • 13 Panel Presumptive Screen for DOA is available for clients who do not perform presumptive screening in their office setting.
  • Testing for the drug class only and yields a positive or negative result.
  • Consult the Stone Clinical Laboratories Test Compendium for ranges of specific drugs within each class, and the AMA CPT code for presumptive screening.

Quantitative Confirmatory Drug and Medication Testing

  • Stone Clinical Laboratories uses LC/MS/MS methodologies to identify and definitively confirm a specific drug/metabolite within a drug class and the quantified concentration of a drug.
  • Stone Clinical Laboratories confirmation panel offers urine confirmation  testing for up to 70 different analytes.
  • The presence of a drug metabolite is a reliable indicator that a person used the parent drug of that metabolite.
  • LC/MS/MS  testing is extremely sensitive and reliable.

DAST-10

Stone Clinical Laboratories has an agreement with The Center for Addiction and Mental Health to utilize the DAST-10 assessment. DAST-10 is a risk stratification tool the can be administered to patients in just minutes.

Download Assessment

  • Risk stratification tool
  • Establishes medical necessity of testing
  • Peer reviewed and easy to administer
  • 78% degree of accuracy for risk of opioid abuse

Toxicology sample report

Download

Toxicology requisition

Download

  1. Christo PJ, Manchikanti L, Ruan X, et al. Urine drug testing in chronic pain. Pain Physician 2011;14:123–43.
  2. Trescot AM, Helm S, Hansen H, et al. Opioids in the management of chronic non-cancer pain: An update of American Society of Interventional Pain Physicians&rsquo (ASIPP) guidelines. Pain Physician 2008;11:S5–62.

Stone Clinical Laboratories